[1]
|
Ogurtsova, K., da Rocha Fernandes, J.D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N.H., Cavan, D., Shaw, J.E. and Makaroff, L.E. (2017) IDF Diabetes Atlas: Global Estimates for the Prevalence of Diabetes for 2015 and 2040. Diabetes Research and Clinical Practice, 128, 40-50. https://doi.org/10.1016/j.diabres.2017.03.024
|
[2]
|
NCD Risk Factor Collaboration (NCD-RisC) (2016) Worldwide Trends in Diabetes since 1980: A Pooled Analysis of 751 Population-Based Studies with 4.4 Million Participants. The Lancet (London, England), 387, 1513-1530.
|
[3]
|
Samsu, N. (2021) Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. BioMed Research International, 2021, Article ID: 1497449. https://doi.org/10.1155/2021/1497449
|
[4]
|
刘羽飞, 任晋玉, 贠捷, 宋业旭, 宋立群. 从肺论治慢性肾衰竭初探[J]. 中医药学报, 2022, 50(3): 5-8.
|
[5]
|
高向峰, 饶向荣, 李深, 成庭柱, 方吕贵, 王秀娟. 肺肾同治法治疗IgA肾病[J]. 中国中医药信息杂志, 2020, 27(3): 118-121.
|
[6]
|
陈仁慈, 项洁琼, 陈洪宇. 冬虫夏草治疗糖尿病肾病疗效的系统评价[J]. 中国中西医结合肾病杂志, 2017, 18(4): 340-344.
|
[7]
|
王悦, 田双双, 刘晓谦, 张永欣, 闫利华, 王智民. 茯苓多糖的提取、结构及药理作用研究进展[J]. 世界中医药, 2021, 16(17): 2548-2555.
|
[8]
|
韩思婕, 潘翔, 朱芊芊, 张丹丹, 张涵瑞, 方敬贤, 魏琼, 刘丹, 叶晓川. 茯苓多糖调节2型糖尿病模型大鼠肝脏糖异生的机制研究[J]. 中国药房, 2022, 33(13): 1581-1587.
|
[9]
|
李佳丹, 周迪夷. 茯苓多糖对db/db小鼠肾脏保护作用及其对p38 MAPK/PPAR-γ信号通路的影响[J]. 中国中医药科技, 2019, 26(3): 346-350.
|
[10]
|
Huang, R., Zhang, M., Tong, Y., Teng, Y., Li, H. and Wu, W. (2022) Studies on Bioactive Components of Red Ginseng by UHPLC-MS and Its Effect on Lipid Metabolism of Type 2 Diabetes Mellitus. Frontiers in Nutrition, 9, Article ID: 865070. https://doi.org/10.3389/fnut.2022.865070
|
[11]
|
陈锐, 陈德经, 张建新. 西洋参多糖肽对糖尿病小鼠降血糖血脂及抗氧化作用研究[J]. 西北农业学报, 2013, 22(11): 195-201.
|
[12]
|
Wan, F., Ma, F., Wu, J., Qiao, X., Chen, M., Li, W. and Ma, L. (2022) Effect of Lyciumbarbarum Polysaccharide on Decreasing Serum Amyloid A3 Expression through Inhibiting NF-κB Activation in a Mouse Model of Diabetic Nephropathy. Analytical Cellular Pathology (Amsterdam), 2022, Article ID: 7847135.
https://doi.org/10.1155/2022/7847135
|
[13]
|
刘涛, 王刚, 吕奇, 陈小娟, 张文菲, 熊玮. 润肺益肾饮联用左卡尼汀对尿毒症维持性血液透析患者营养不良、微炎症状态和生活质量的影响[J]. 现代中西医结合杂志, 2021, 30(4): 364-368.
|
[14]
|
刘涛, 吕奇, 陈小娟, 张文菲, 王刚, 高智. 润肺益肾饮对维持性血液透析脾肾两虚型患者微炎症的影响[J]. 中医药导报, 2020, 26(10): 62-65.
|
[15]
|
Zhao, J., Mo, C., Shi, W., Meng, L. and Ai, J. (2021) Network Pharmacology Combined with Bioinformatics to Investigate the Mechanisms and Molecular Targets of Astragalus Radix-Panax notoginseng Herb Pair on Treating Diabetic Nephropathy. Evidence-Based Complementary and Alternative Medicine: eCAM, 2021, Article ID: 9980981.
https://doi.org/10.1155/2021/9980981
|
[16]
|
Hu, T., Yue, J., Tang, Q., Cheng, K.W., Chen, F., Peng, M., Zhou, Q. and Wang, M. (2022) The Effect of Quercetin on Diabetic Nephropathy (DN): A Systematic Review and Me-ta-Analysis of Animal Studies. Food & Function, 13, 4789-4803. https://doi.org/10.1039/D1FO03958J
|
[17]
|
Khan, Z., Nath, N., Rauf, A., Emran, T.B., Mitra, S., Islam, F., Chandran, D., Barua, J., Khandaker, M.U., Idris, A.M., Wilairatana, P. and Thiruvengadam, M. (2022) Multifunctional Roles and Pharmacological Potential of β-Sitosterol: Emerging Evidence toward Clinical Applications. Chemico-Biological Interactions, 365, Article ID: 110117.
https://doi.org/10.1016/j.cbi.2022.110117
|
[18]
|
Alam, M.B., Chowdhury, N.S., Sohrab, M.H., Rana, M.S., Hasan, C.M. and Lee, S.H. (2020) Cerevisterol Alleviates Inflammation via Suppression of MAPK/NF-κB/AP-1 and Activation of the Nrf2/HO-1 Signaling Cascade. Biomolecules, 10, 199. https://doi.org/10.3390/biom10020199
|
[19]
|
Jayaraman, S., Devarajan, N., Rajagopal, P., Babu, S., Ganesan, S.K., Veeraraghavan, V.P., Palanisamy, C.P., Cui, B., Periyasamy, V. and Chandrasekar, K. (2021) β-Sitosterol Circumvents Obesity Induced Inflammation and Insulin Resistance by down-Regulating IKKβ/NF-κB and JNK Signaling Pathway in Adipocytes of Type 2 Diabetic Rats. Molecules (Basel, Switzerland), 26, 2101. https://doi.org/10.3390/molecules26072101
|
[20]
|
陈光志. sEH基因敲除治疗STZ诱导的小鼠糖尿病肾病的作用及其机制[D]: [博士学位论文]. 武汉: 华中科技大学, 2013.
|
[21]
|
Fan, F. and Roman, R.J. (2017) Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology. Journal of the American Society of Nephrology: JASN, 28, 2845-2855. https://doi.org/10.1681/ASN.2017030252
|
[22]
|
Wang, J. and Zhuang, S. (2017) Src Family Kinases in Chronic Kidney Disease. American Journal of Physiology. Renal Physiology, 313, F721-F728. https://doi.org/10.1152/ajprenal.00141.2017
|
[23]
|
Zhou, D. and Liu, Y. (2016) Therapy for Kidney Fibrosis: Is the Src Kinase a Potential Target? Kidney International, 89, 12-14. https://doi.org/10.1016/j.kint.2015.10.007
|
[24]
|
Hu, Y., Liu, S., Liu, W., Zhang, Z., Liu, Y., Li, S., Sun, D., Zhang, G. and Fang, J. (2022) Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 15, 943-962.
https://doi.org/10.2147/DMSO.S350062
|
[25]
|
Chen, H.M., Dai, J.J., Zhu, R., Peng, F.F., Wu, S.Z., Yu, H., Krepinsky, J.C. and Zhang, B.F. (2019) Parathyroid Hormone-Related Protein Induces Fibronectin Up-Regulation in Rat Mesangial Cells through Reactive Oxygen Species/Src/EGFR Signaling. Bioscience Reports, 39, BSR20182293. https://doi.org/10.1042/BSR20182293
|
[26]
|
Yan, Y., Ma, L., Zhou, X., Ponnusamy, M., Tang, J., Zhuang, M.A., Tolbert, E., Bayliss, G., Bai, J. and Zhuang, S. (2016) Src Inhibition Blocks Renal Interstitial Fibroblast Activation and Ameliorates Renal Fibrosis. Kidney International, 89, 68-81. https://doi.org/10.1038/ki.2015.293
|
[27]
|
项昌培, 周瑞, 张晶晶, 杨洪军. 三七对糖尿病肾病、糖尿病脑病和糖尿病心肌病“异病同治”的网络药理学作用机制分析[J]. 中国中药杂志, 2021, 46(10): 2424-2433.
|
[28]
|
Sun, Y., Deng, M., Ke, X., Lei, X., Ju, H., Liu, Z. and Bai, X. (2021) Epidermal Growth Factor Protects against High Glucose-Induced Podocyte Injury Possibly via Modulation of Autophagy and PI3K/AKT/mTOR Signaling Pathway Through DNA Methylation. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 14, 2255-2268.
https://doi.org/10.2147/DMSO.S299562
|
[29]
|
Harskamp, L.R., Gansevoort, R.T., van Goor, H. and Meijer, E. (2016) The Epidermal Growth Factor Receptor Pathway in Chronic Kidney Diseases. Nature Reviews. Nephrology, 12, 496-506. https://doi.org/10.1038/nrneph.2016.91
|
[30]
|
Li, S. and Xu, G. (2022) QishenYiqi Dripping Pill Protects Diabetic Nephropathy by Inhibiting the PI3K-AKT Signaling Pathways in Rats. Evidence-Based Complementary and Alternative Medicine: eCAM, 2022, Article ID: 6239829.
https://doi.org/10.1155/2022/6239829
|
[31]
|
Qian, Y., Sun, X., Wang, X., Yang, X., Fan, M., Zhong, J., Pei, Z. and Guo, J. (2021) Mechanism of Cordyceps Cicadae in Treating Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking Analysis. Journal of Diabetes Research, 2021, Article ID: 5477941. https://doi.org/10.1155/2021/5477941
|
[32]
|
Yuan, L., Zhang, F., Shen, M., Jia, S. and Xie, J. (2019) Phytosterols Suppress Phagocytosis and Inhibit Inflammatory Mediators via ERK Pathway on LPS-Triggered Inflammatory Responses in RAW264.7 Macrophages and the Correlation with Their Structure. Foods (Basel, Switzerland), 8, 582. https://doi.org/10.3390/foods8110582
|
[33]
|
Sifuentes-Franco, S., Padilla-Tejeda, D.E., Carrillo-Ibarra, S. and Miranda-Díaz, A.G. (2018) Oxidative Stress, Apoptosis, and Mitochondrial Function in Diabetic Nephropathy. International Journal of Endocrinology, 2018, Article ID: 1875870. https://doi.org/10.1155/2018/1875870
|
[34]
|
Steenbeke, M., Speeckaert, R., Desmedt, S., Glorieux, G., Delanghe, J.R. and Speeckaert, M.M. (2022) The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases. International Journal of Molecular Sciences, 23, 3439. https://doi.org/10.3390/ijms23073439
|
[35]
|
杨超茅, 杨志新, 马晓玲. AGEs-RAGE信号通路在糖尿病肾病中的作用机制及中医药研究进展[J]. 中医学报, 2019, 34(9): 1864-1868.
|
[36]
|
Pathomthongtaweechai, N. and Chutipongtanate, S. (2020) AGE/RAGE Signaling-Mediated Endoplasmic Reticulum Stress and Future Prospects in Non-Coding RNA Therapeutics for Diabetic Nephropathy. Biomedicine & Pharmacotherapy, 131, Article ID: 110655. https://doi.org/10.1016/j.biopha.2020.110655
|